| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 7 | +100.00% | +6.80% | -0.19% | +6.99% | +5.40% | — |
| 14d | 7 | +100.00% | +10.08% | -1.61% | +11.69% | +11.10% | — |
| 30d | 7 | +100.00% | +25.51% | +1.27% | +24.24% | +22.39% | — |
| 60d | 7 | +85.71% | +23.06% | +3.43% | +19.63% | +23.16% | — |
| 90d | 7 | +85.71% | +152.72% | +4.41% | +148.31% | +170.95% | — |
| 180d | 7 | +100.00% | +108.47% | +9.89% | +98.58% | +110.54% | — |
| 1y | 7 | +85.71% | +2126.72% | +15.22% | +2111.50% | +2401.19% | — |
| 2y | 7(6 pending) | +100.00% | +1268.85% | +44.22% | +1224.64% | +1224.64% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| QNCX QUINCE THERAPEUTICS, INC. | SALEGRANT Stock grant | 365,000 | — | — | 365,000 | Jan 23, 2026 | Jan 23, 2026 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | SALE CBO, COO & CCO | 25,280 | — | — | 199,720 | Dec 5, 2025 | Dec 6, 2025 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | SALE CBO, COO & CCO | 2,271 | — | — | 45,168 | Dec 5, 2025 | Dec 6, 2025 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE CBO, COO & CCO | 25,280 | $0.94 | $23.8K | 361,827 | Dec 5, 2025 | Dec 6, 2025 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE CBO, COO & CCO | 2,271 | $0.55 | $1.2K | 336,547 | Dec 5, 2025 | Dec 6, 2025 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 37,736 | $1.20 | $45.3K | 334,276 | Jun 18, 2025 | Jun 20, 2025 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 37,736 | $0.13 | $4.7K | 37,736 | Jun 18, 2025 | Jun 20, 2025 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 450,000 | — | — | 450,000 | Jan 28, 2025 | Feb 11, 2025 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE CHIEF BUSINESS OFFICER AND COO | 23,565 | $0.63 | $14.8K | 296,540 | Aug 21, 2024 | Aug 21, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE CHIEF BUSINESS OFFICER AND COO | 2,280 | $0.61 | $1.4K | 267,975 | Aug 21, 2024 | Aug 21, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE CHIEF BUSINESS OFFICER AND COO | 5,000 | $0.62 | $3.1K | 272,975 | Aug 21, 2024 | Aug 21, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE CHIEF BUSINESS OFFICER AND COO | 2,500 | $0.61 | $1.5K | 262,271 | Aug 20, 2024 | Aug 21, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE CHIEF BUSINESS OFFICER AND COO | 3,424 | $0.60 | $2.1K | 265,695 | Aug 20, 2024 | Aug 21, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE CHIEF BUSINESS OFFICER AND COO | 2,155 | $0.58 | $1.2K | 259,771 | Aug 19, 2024 | Aug 21, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | SALE CHIEF BUSINESS OFFICER AND COO | 56,061 | — | — | 47,439 | Jun 4, 2024 | Jun 5, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE CHIEF BUSINESS OFFICER AND COO | 56,061 | $0.55 | $30.8K | 257,616 | Jun 4, 2024 | Jun 5, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 600,000 | — | — | 600,000 | Feb 1, 2024 | Feb 1, 2024 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Oct 24, 2023 | Oct 25, 2023 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASE Chief Business Officer | 71,762 | $1.22 | $87.5K | 201,555 | Aug 8, 2023 | Aug 9, 2023 ↗ | View → |
| QNCX QUINCE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 225,000 | — | — | 225,000 | Feb 1, 2023 | Feb 2, 2023 ↗ | View → |